Relationship between thyroid hormones and fibrinogen levels

Blood Coagulation and Fibrinolysis

Volumn 10, Issue 8, 1999, Pages 481-486

  Chadarevian, R ^a   Bruckert, E ^a   Giral, P ^a   Turpin, G ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Atherosclerosis; Fibrinogen; Thrombosis; Thyroid hormones; Thyroxine

Indexed keywords

CHOLESTEROL; FIBRINOGEN; THYROID HORMONE;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; SMOKING; THYROXINE BLOOD LEVEL;

EID: 0033377826     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199912000-00005     Document Type: Article

References (31)

1. Tachman ML, Guthrie GP. Hypothyroidism: diversity of presentation. Endocr Rev 1984; 5: 456-465.
2. Ford HC, Carter JM. Haemostasis in hypothyroidism. Postgrad Med J 1990; 66: 280-284.
3. Klein M, Barbé F, Kaminsky P, Duc M. Haemostatic disorders in thyroid diseases. Pathol Biol 1993; 41: 268-275.
4. Myrup B, Bregengard C, Faber JF. Primary haemostasis in thyroid disease. J Intern Med 1995; 238: 59-63.
5. Chadarevian R, Bruckert E, Ankri A, Beucler I, Giral P, Turpin G. Relationship between thyroid hormones and plasma D-Dimer levels. Thromb Haemost 1998; 79: 99-103.
6. Bruckert E, De Gennes JL, Dairou F, Turpin G. Fréquence des hypothyroïdies dans une population de sujets hyperlipidémiques. Presse Médicale 1993; 2: 57-60.
7. Diekman T, Lansberg PJ, Kastelein JJP, Wiersinga WM. Prevalence and correction of hypothyroidism in a large cohort of patients referred for dyslipidemia. Arch Int Med 1995; 155: 1490-1495.
8. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease. The Framingham study. JAMA 1987; 258: 1183-1186.
9. Qizilbash N. Fibrinogen and cerebrovascular disease. Eur Heart J 1995; 16 (suppl A): 42-46.
10. Ernst E, Resch KL. Therapeutic interventions to lower plasma fibrinogen concentration. Eur Heart J 1995; 16 (suppl A): 47-53.
11. Koenig W, Sund M, Ernst E, Mraz W, Hombach V, Keil U. Association between rheology and components of lipoproteins in human blood. Results from the MONICA project. Circulation 1992; 85: 2197-2204.
12. Lowe GDO, Fowkes FGR, Dawes J, Donnan PT, Lennie SE, Housley E. Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburg artery study. Circulation 1993; 87: 1915-1920.
13. Sweetnam PM, Thomas HF, Yarnell JWG, Beswick AD, Baker IA, Elwood PC. Fibrinogen, viscosity and the ten year incidence of ischaemic heart disease. The Caerphilly and Speedwell studies. Eur Heart J 1996; 17: 1814-1820.
14. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 1993; 118: 956-963.
15. Levenson J, Giral P, Razavian M, Gariepy J, Simon A. Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors. Arterioscler Thromb Vasc Biol 1995; 15: 1263-1268.
16. Levenson J, Giral P, Megnien JL, Gariepy J, Plainfosse MC, Simon A. Fibrinogen and its relations to sub-clinical extracoronary and coronary atherosclerosis in hypercholesterolemic men. Arterioscler Thromb Vasc Biol 1997; 17:45-50.
17. Folsom AR. Epidemiology of fibrinogen. Eur Heart J 1995; 16 (suppl A): 21-24.
18. Nieuwenhuizen W. Biochemistry and measurement of fibrinogen. Eur Heart J 1995; 16 (suppl A): 6-10.
19. Perk M, O'Neill BJ. The effect of thyroid hormone therapy on angiographic coronary artery disease progression. Can J Cardiol 1997; 13: 273-276.
20. Polikar R, Burger AG, Scherrer U, Nicod P. The thyroid and the heart. Circulation 1993; 87: 1435-1441.
21. Gomberg-Maitland M, Frishman WH. Thyroid hormone and cardiovascular disease. Am Heart J 1998; 135: 187-196.
22. Krasner LJ, Wendling WW, Cooper SC, Chen D, Hellmann SK, Eldridge CJ, et al. Direct effects of triodothyronine on human internal mammary artery and saphenous veins. J Cardiothor Vasc Anesthesia 1997; 11: 463-466.
23. Packard CJ, Shepherd J, Lindsay GM, Gaw A, Taskinen MR. Thyroid replacement therapy and its influence on postheparin plasma lipases and apolipoprotein B metabolism in hypothyroidism. J Clin Endocrinol Metab 1993; 76: 1209-1216.
24. Tan KCB, Shiu SWM, Kung AWC. Plasma cholesteryl ester transfer protein activity in hyper and hypothyroidism. J Clin Endocrinol Metab 1998; 83: 140-143.
25. Erfurth EM, Ericsson UB, Egervall K, Lethagen SR. Effect of acute desmopressin and of long-term thyroxine replacement on haemostasis in hypothyroidism. Clin Endocrinol 1995; 42: 373-378.
26. Mooradian AD. Normal age-related changes in thyroid hormone economy. Clin Geriatric Med 1995; 11: 159-169.
27. Muller B, Zulewski H, Huber P, Ratcliffe JG, Staub JJ. Impaired action of thyroid hormone associated with smoking in women with hypothyroidism. N Engl J Med 1995; 333: 964-969.
28. Giansante C, Fiotti N, Cattin L, Da Col PG, Calabrese S. Fibrinogen, D-Dimer and thrombin-antithrombin complexes in a random population sample: relationship with other cardiovascular risk factors. Thromb Haemost 1994; 71: 581-586.
29. Lee AJ, Fowkes FGR, Lowe GDO, Rumley A. Determinants of fibrin D-Dimer in the Edinburg artery study. Arterioscler Thromb Vasc Biol 1995; 15: 1094-1097.
30. Graninger W, Pirich KR, Speiser W, Deutsch E, Waldhausl WK. Effect of thyroid hormones on plasma protein concentration in man. J Clin Endocrinol Metab 1986; 63: 407-411.
31. Rosenfeld BA, Faraday N, Campbell D, Dise K, Bell W, Goldschmidt P. Hemostatic effects of stress hormone infusion. Anesthesiology 1994; 81: 1116-1126.